← All organizations
Highest phase reached
Phase 3
Timeline
2000s
- Jan 1, 2003
Athenex, Inc.— Founded
- Apr 23, 2004
terbutaline— Marketing Organization
2020s
- May 5, 2021
Kuur Therapeutics— Acquired
Drugs by trial phase (19 distinct, 38 trials)
Phase 3 (2 own, 1 via acquisition)
Phase 2 (1 own, 3 via acquisition)
Phase 1 (12 own, 0 via acquisition)
Indications
Marketed drugs (70)
Subsidiaries (1 direct, 3 total across the full acquisition tree)
Recent trials (48)
- NCT05487651Lead sponsorPhase 1Oct 31, 2022
- NCT04878484Lead sponsorPhase 1Aug 11, 2021
- NCT04136834Lead sponsorPhase 1Nov 15, 2019
- NCT04013217Study directorPhase 1Jul 15, 2019
- NCT04013217Lead sponsorPhase 1Jul 15, 2019
- NCT04993040Lead sponsorPhase 1Apr 22, 2019
- NCT03892018Lead sponsorPhase 1Mar 27, 2019
- NCT03892018Study directorPhase 1Mar 27, 2019
- NCT03575780Study chairPhase 1Aug 31, 2018
- NCT03575780Lead sponsorPhase 1Aug 31, 2018
- NCT03544567Study directorPhase 1Jul 31, 2018
- NCT03544567Lead sponsorPhase 1Jul 31, 2018
- NCT03588039Study directorPhase 1Jul 30, 2018
- NCT03588039Lead sponsorPhase 1Jul 30, 2018
- NCT03987685Lead sponsorPhase 1Jul 19, 2018
Details
- Founded
- Buffalo, NY, US Jan 1, 2003
- Last known activity
- Oct 31, 2022